Drug companies exaggerate — controlling drug prices won't threaten innovation

The Hill

13 November 2019 - It is hard to not be impressed by the progress Americans have made in combatting diseases. Cures for hepatitis C and advances in breast cancer treatments have changed lives. 

This is in part due to scientific breakthroughs at our national laboratories, universities and the pharmaceutical industry. But progress creating new drugs has led to a new problem: a drug pricing crisis.

Nearly 1 in 3 American adults report not taking their medicines as prescribed because of the cost. In Washington and across the country, people are engaged in a spirited debate about the affordability of prescription drugs for households and public budgets.

Read The Hill article

Michael Wonder

Posted by:

Michael Wonder